Bishops Stortford, United Kingdom

Kamal Al-Barazanji


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kamal Al-Barazanji: Innovator in Medical Research

Introduction

Kamal Al-Barazanji is a notable inventor based in Bishops Stortford, GB. He has made significant contributions to the field of medical research, particularly in the development of treatments for various diseases. His innovative work has led to the filing of a patent that addresses critical health issues.

Latest Patents

Kamal Al-Barazanji holds a patent for a method of finding agonists and antagonists to human and rat GPR14. This patent includes human GPR14 polypeptides and polynucleotides, along with methods for producing such polypeptides through recombinant techniques. The patent outlines the utilization of these polypeptides and polynucleotides in designing protocols for treating ischemic coronary artery disease, atherosclerosis, metabolic diseases, and various other health conditions. His work encompasses a wide range of diseases, including cancer, autoimmune disorders, and neurological conditions.

Career Highlights

Throughout his career, Kamal Al-Barazanji has worked with prominent companies such as SmithKline Beecham Corporation and Sb Laboratoires Pharmaceutiques. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Kamal has collaborated with esteemed colleagues, including Nambi V Aiyar and Robert S Ames. These partnerships have enhanced his research efforts and expanded the impact of his work in the medical field.

Conclusion

Kamal Al-Barazanji is a distinguished inventor whose contributions to medical research have the potential to improve the treatment of various diseases. His innovative patent and collaborations with other professionals highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…